Skip to main content

XPO Logistics Begins US Deliveries of COVID-19 Vaccine

Written by Customer Service on . Posted in Public Companies.

GREENWICH, Conn., Dec. 18, 2020 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO) has confirmed that its expedited transportation fleet began delivering Pfizer-BioNTech COVID-19 vaccine shipments this week in support of Operation Warp Speed, the US government’s public-private alliance to combat the pandemic. XPO is a global expert in cold-chain logistics and one of North America’s largest managers of expedited shipments.
The company has deployed its fleet of state-of-the-art tractor-trailers to support partners in moving the heat-sensitive vaccine to US distribution points and healthcare facilities. The thermal-mapped equipment is outfitted with sensors that constantly monitor the temperature inside the trailer and alert the driver to any variances. XPO has allocated additional transportation resources to handle COVID-19 vaccines awaiting approval for emergency use.“This is an evolving situation, and we’re working closely with manufacturers and other major carriers to make sure the states have everything they need,” said Malcolm Wilson, XPO Logistics chief executive officer for Europe. “In addition to the vaccine, we’re also moving large volumes of saline, syringes and gloves. I’m proud of how quickly industry competitors became collaborators to complete these critical shipments.”    XPO routinely transports vaccines for its pharmaceutical customers, and Wilson noted that the company is no stranger to mounting an expedited response – a service XPO has offered its customers for more than three decades. Additionally, the company can provide safe storage of temperature-controlled pharmaceuticals as needed at its ISO-certified cold-chain warehouses.“We have specialists who focus on arranging urgent shipments of pharmaceuticals and biologics using our XPO Connect digital transportation platform,” Wilson said. “The technology adds another layer of security to the strong protocols maintained at ground level by our drivers and dispatchers. We have continuous visibility of the trucks and external conditions, so we can make adjustments in real time.”Throughout the pandemic, XPO has transported products used in the treatment of COVID-19, including therapeutic drugs, over-the-counter medicines and personal protective equipment. Recently, the company dedicated additional resources to deliver the essential supplies needed for large-scale vaccination efforts in North America and Europe.About XPO Logistics
XPO Logistics, Inc. (NYSE: XPO) is a top ten global logistics provider of cutting-edge supply chain solutions to the most successful companies in the world. The company operates as a highly integrated network of people, technology and physical assets in 30 countries, with 1,499 locations and approximately 97,000 employees. XPO uses its network to help more than 50,000 customers manage their goods most efficiently throughout their supply chains. XPO’s corporate headquarters are in Greenwich, Conn., USA, and its European headquarters are in Lyon, France. xpo.comMedia Contact
XPO Logistics, Inc.
Joe Checkler
+1-203-423-2098
joe.checkler@xpo.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.